Compositions comprising angiogenic factors and methods of use thereof

Recombinant vaccine strains and methods of producing the same

Methods for constructing antibiotic resistance free vaccines

Modified meningococcal fHbp polypeptides

Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium

Production of polypeptides relevant to human and animal health using

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Recombinant vaccine strains and methods of using the same in cancer immunotherapy

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

Recombinant expressing colonization factor antigen I (CFA/I) fimbriae and their methods of use

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS

Vaccine and therapeutic delivery system

Epidermal growth factor receptor variant III-mesothelin fusions and methods of using the same

Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

Immunogenic fusion proteins for the treatment of cancer

Listeria-based adjuvants

NOVEL MSLN TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY

Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria

Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

Use of vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals

DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS

Proteins and nucleic acids from meningitis/sepsis-associated

Method of inducing tolerance to an allergen

COMBINATION THERAPY FOR USE IN CANCER THERAPY

Compositions and methods for treatment of cancer using bacteria

Live bacterial vectors for prophylaxis or treatment

Immunogenic formulation containing recombinant live BCG that express antigens of metapneumovirus (hMPV), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use

Methods of using presenting N-glycan or derivatives thereof

Compositions and methods for the treatment or prevention of tuberculosis

Compositions comprising angiogenic factors and methods of use thereof

Developments in meningococcal outer membrane vesicles

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

Compositions and methods for treatment of cancer using bacteria

Recombinant polypeptide construct comprising multiple enterotoxigenic fimbrial subunits

Campylobacter immunogenic compositions and uses thereof

Recombinant as a vaccine

Immunotherapy composition and use thereof

Methods and compositions using for enhancing immunogenicity by prime boost

Genetically modified babesia parasites expressing protective tick antigens and uses thereof

Composition and uses thereof

Modified gram positive bacteria and uses thereof

Chimeras of lumazine synthase and beta subunit of ABtoxins

Compositions and methods of enhancing immune responses

Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax

Attenuated bacteria and methods of using

Production of polypeptides relevant to human and animal health using

Oral vaccine having improved cellular immunity induction potency

Genetically modified as vaccines against species

Oral Vaccine For Borrelia

Methods and compositions for inducing an immune response to EGFRvIII

-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1

OMV vaccines

Method for treating pancreatic cancer with vaccine

Bacillus based delivery system and methods of use

Vaccine and therapeutic delivery system

Attenuated strains

Campylobacter vaccine

Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

Compositions and methods of enhancing immune responses to enteric pathogens

Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer

Prevention and treatment of mycobacterium infection

Immunogenic polypeptide surface layer-expressing bifidobacterium

Modified listeria bacteria and uses thereof

Crimean-congo haemorrhagic fever virus antigenic composition

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for associated disease (CDAD)

Vaccines for control of epidemic generated by markerless gene deletion

Compositions and methods comprising KLK3 or FOLH1 antigen

Cyclic di-AMP induction of type I interferon

Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof

Attenuated mutant as a vaccine vector for the delivery of exogeneous antigens

PRODUCTION OF RECOMBINANT VACCINE IN E.COLI BY ENZYMATIC CONJUGATION

Adhesin as immunogen against enterotoxigenic

Live attenuated Shigella vaccine

Multifunctional oral vaccine based on chromosome recombineering

HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto

Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

Compositions and methods of enhancing immune responses to Eimeria

MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE

Recombinant strains

Method of using attenuated bordetella strains

Plague vaccine

Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers

Modulation of yeast-based immunotherapy products and responses

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Vaccine vectors and methods of enhancing immune responses

Vaccine and methods to reduce campylobacter infection

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

Live, oral vaccine for protection against serotype 1

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

DNA vaccine for use in pancreatic cancer patients

Tumor vaccination involving a humoral immune response against self-proteins

Recombinant strain of calmette-guerin (BCG), immunogenic composition and use

typhi Ty21a expressing F1-V fusion protein and uses thereof

Composition comprising a colloidal synthetic bioresorbable vector and a viral vector

Recombinant bacterium and uses thereof

Methods and compositions using listeria for enhancing immunogenicity by prime boost

Methods for constructing antibiotic resistance free vaccines

Yeast-based therapeutic for chronic hepatitis B infection

Suppressor cell function inhibition following vaccine treatment

Recombinant polypeptide construct comprising multiple enterotoxigenic fimbrial subunits

Canine babesiosis vaccine antigen

Compositions comprising angiogenic factors and methods of use thereof

Rodent parasites as platforms for a whole-organism malaria vaccine

Subunit vaccine delivery platform for robust humoral and cellular immune responses

Live recombinant booster vaccine against tuberculosis

RECOMBINANT BACTERIUM FOR INDUCTION OF CELLULAR IMMUNE RESPONSE

Oral Vaccine For Borrelia

Mucosal immunization to prevent prion infection

Diatom-based vaccines

Methods of transforming a

immunogenic compositions and uses thereof

Live bacterial vaccines resistant to carbon dioxide (CO), acidic pH and/or osmolarity for viral infection prophylaxis or treatment

Tuberculosis compositions and methods of using the same

Proteins and nucleic acids from meningitis/sepsis-associated

HIV consensus envelope sequences and methods for using the same

Attenuated and adapted strain of pseudomonas for delivering antigens

Dual delivery system for heterologous antigens

Induction of mucosal tolerance to antigens

DNA vaccines against tumor growth and methods of use thereof

Induction of mucosal tolerance to antigens

Engineered and methods of use thereof

IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same

Dual delivery system for heterologous antigens

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

Immunogenic compositions and methods therefor

Modified gram positive bacteria and uses thereof

Live bacterial vaccines for prophylaxis or treatment of infection

RECOMBINANT BCG STRAINS WITH ENHANCED ABILITY TO INHIBIT INTRACELLULAR MYCOBACTERIAL GROWTH

Listeria-based adjuvants

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

hTERT sequences and methods for using the same

Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins

Pathogenic bacteria

Live, oral vaccine for protection against serotype 1

Vaccine and drug delivery by intranasal application of vector and vector extracts

Compositions and methods of enhancing immune responses

Recombinant expressing colonization factor antigen I (CFA/I) fimbriae and their methods of use

Compositions and methods for the treatment or prevention of human adenovirus-36 infection

Mesothelin vaccines and model systems

Methods and compositions for inducing an immune response to EGFRvIII

Compositions and methods to elicit immune responses against pathogenic organisms using yeast-based vaccines

Fusion protein for secretory protein expression

Recombinant bacterium comprising a toxin/antitoxin system

Recombinant mycobacterium as a vaccine

Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus

Methods and compositions using listeria for adjuvant treatment of cancer

Vaccine against

Recombinant mycobacterium as vaccine for use in humans

Use of vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals

Developments in meningococcal outer membrane vesicles

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

Synthetic lipid biology for combinatorial engineering of endotoxin

ORAL VACCINE FOR AQUATIC ANIMALS

Recombinant trypanosoma theileri parasite

OMV vaccines

Vaccine for protection against and Porcine circo virus

Vaccines comprising heat-sensitive transgenes

V. Cholera hypereexpressing recombinant cholera toxin B subunit showing dual immunogenicity

Vaccine and methods to reduce campylobacter infection

YEAST-BASED VACCINES AS IMMUNOTHERAPY

YEAST-HIV ANTIGEN COMPOSITIONS AND METHODS OF USING THE SAME

Tumor vaccination involving a humoral immune response against self-proteins

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS

Bacterium comprising a regulated nucleic acid

HIV consensus envelope sequences and methods for using the same

Modulation of yeast-based immunotherapy products and responses

Methods of transforming a

LENTIVIRUS VACCINE BASED ON THE RECOMBINANT VIRAL VACCINE AGAINST YELLOW FEVER

Leishmania-based carrier for vaccine delivery

DNA promoters and anthrax vaccines

Multivalent live vector vaccine against -associated disease

Vaccine vectors and methods of enhancing immune responses

Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

IMMUNOPROTECTION BY ORAL ADMINISTRATION OF RECOMBINANT LACTOCOCCUS LACTIS MINI-CAPSULES

Vaccine against cholera and enterotoxigenic (ETEC) diarrhea

Method producing an immune response for reducing the risk of developing brucellosis

Producing an immune response for reducing the risk of developing brucellosis

Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and

Vaccines comprising heat-sensitive transgenes

Microbial vaccine and vaccine vector

Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition

Antigen compositions and methods of inhibiting bacterial infection and uses of the antigen compositions

Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology

Gene expressing a bifidobacterium surface-presented fusion protein

system and uses thereof

Compositions and methods for treatment of cervical dysplasia

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM

Strain of s. typhimurium, its use and a method to obtain a therapeutic vaccine vector

Cyclic di-AMP induction of type I interferon

Methods for the Prevention of Malaria

RECOMBINANT MYCOBACTERIUM STRAIN EXPRESSING A MYCOBACTERIAL FAP PROTEIN UNDER THE CONTROL OF A PROMOTER ACTIVE UNDER HYPOXIA AND ITS APPLICATION FOR CANCER THERAPY

DNA promoters and anthrax vaccines

Live bacterial vaccines for viral infection prophylaxis or treatment

RECOMBINANT PROTECTIVE PROTEIN FROM STREPTOCOCCUS PNEUMONIAE

MULTIPLE DELIVERY SYSTEM FOR HETEROLOGOUS ANTIGENS

Influenza vaccine, composition, and methods of use

Engineered listeria and methods of use thereof

Compositions comprising angiogenic factors and methods of use thereof

IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION

Combination immunotherapy compositions against cancer and methods

presenting N-glycan or derivatives thereof

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C

Attenuated enterohemorrhagic -based vaccine vector and methods relating thereto

AUXOTROPHIC RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF IN THE CONTROL OF HUMAN INFECTIONS CAUSED BY PARASITES

Recombinant bacterium and methods of antigen and nucleic acid delivery

Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria

Mesothelin vaccines and model systems

Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems

Method for treating cancer with vaccine

LIVE ATTENUATED VACCINES

Live, oral vaccine for protection against serotype 1

Compositions and methods for the therapy and diagnosis of inflammatory bowel disease

VACCINES AGAINST CLOSTRIDIUM DIFFICILE AND METHODS OF USE

CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURES

Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors

Stable constitutively high expression vector for preparing HPV vaccine and recombinant lactic acid bacteria transformed thereby

Oral vaccine

IMMUNOTHERAPEUTIC, ANTI-TUMORIGENIC COMPOSITIONS AND METHODS OF USE THEREOF

Method for the oral/mucosal vaccination by means of recombinant yeasts

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

COMPOSITIONS COMPRISING PRFA* MUTANT LISTERIA AND MEHTODS OF USE THEREOF

Recombinant bacterium capable of eliciting an immune response against

Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof

Multivalent vaccines comprising recombinant viral vectors

based delivery system and methods of use

Helicobacter system and uses thereof

vectored vaccines against and methods of use

Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins

Recombinant bacterium capable of eliciting a protective immune response against

Multivalent vaccines comprising recombinant viral vectors

Immunotherapy for chronic hepatitis C virus infection

Engineered Listeria and methods of use thereof

Methods and compositions for treating

IDENTIFICATION OF GENES

LIVE LISTERIA-BASED VACCINES FOR CENTRAL NERVOUS SYSTEM THERAPY

Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof

attenuated for entry into non-phagocytic cells, vaccines comprising the and methods of use thereof

Immunogenic formulation

Live attenuated aldolase-negative bacterial vaccine

Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria

vaccine

Piscirickettsia salmonis antigens and use thereof

Yeast-based vaccines as immunotherapy

REDUCED COLONIZATION OF MICROBES AT THE MUCOSA

Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors

Fermentation process

DUAL DELIVERY SYSTEM FOR HETEROLOGOUS ANTIGENS

Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

Compositions and methods of enhancing immune responses to

Immunogenic compositions for gram positive bacteria such as

Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines

Method of inducing tolerance to an allergen

VACCINE COMPOSITIONS AND USES THEREOF

Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response

Engineered pertactin variants for vaccine use

Vaccine Antigens from Piscirickettsia Salmonis

Attenuated vaccine against fish pathogen sp

Formulation for room temperature stabilization of a live attenuated bacterial vaccine

IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION

Recombinant Double-Stranded RNA Phage, and Use of the Same

Recombinant bacterium capable of eliciting an immune response against enteric pathogens

VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS

Methods of eliciting or boosting a cellular immune response

Compositions and methods of enhancing immune responses

MICROBIAL DELIVERY SYSTEM

VACCINE TARGETS AND DELIVERY SYSTEMS FOR CRYPTOSPORIDIUM

Recombinant attenuated clostridium organisms and vaccine

Vaccine Antigens

VIRULENCE GENES, PROTEINS, AND THEIR USE

IMMUNOTHERAPY FOR PROSTATE CANCER USING RECOMBINANT BACILLE CALMETTE-GUERIN EXPRESSING PROSTATE SPECIFIC ANTIGENS

Recombinant bacterium

Immunoprotective influenza antigen and its use in vaccination

ATTENUATED LISTERIA SPP. AND METHODS FOR USING THE SAME

Antibiotic resistance free strains and methods for constructing and using same

Clostridial toxin NetB

Dendritic cell binding proteins and uses thereof

Vaccine against

Recombinant BCG strains with enhanced ability to escape the endosome

Methods and compositions using for enhancing immunogenicity by prime boost

based delivery system and methods of use

Producing an immune response for reducing the risk of developing brucellosis

KENNEL COUGH VACCINE

Methods and compositions for treating tularemia

Ras mutation and compositions and methods related thereto

vaccines and uses thereof

Yeast-Based Vaccine for Inducing an Immune Response

Meningococcal vaccines including hemoglobin receptor

Use of coccidian

Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

Method of inducing immune tolerance to type I diabetes

Methods and reagents for decreasing clinical reaction to allergy

Recombinant attenuated organisms and vaccine

HPV vaccines and methods for using the same

DNA promoters and anthrax vaccines

Yeast-based therapeutic for chronic hepatitis C infection

COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE